Autoantibody profiling using microarray identifies biomarkers associated with chemoimmunotherapy efficacy and immune-related adverse events in lung cancer patients
Zuo Wang(Shanghai University of Engineering Science), Xiaobo Yu(Beijing Proteome Research Center), Qian Niu(Beijing Proteome Research Center), Bingwei Wang(Nanjing University of Chinese Medicine), Qiuchi Chen(Union Hospital), Ruimin Liu(Beijing Proteome Research Center), Yang Dong(Academy of State Administration of Grain), Bo Yu(Beijing Proteome Research Center), Xiaohan Zhang(Beijing Proteome Research Center), Lu Chen(Shanghai Medical College of Fudan University), Xingming Xu(Beijing Proteome Research Center), Zheng Cao(Beijing Obstetrics and Gynecology Hospital), Yongmei Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Ying Wu(Beijing Obstetrics and Gynecology Hospital), Yuxin Jiao(Fudan University), S. J. Guo(Anhui Medical University), Xiaomei Zhang(Tang Hospital), Jia Lv(Beijing Proteome Research Center), Di Hu(Beijing Proteome Research Center), Qiaoyun Tan(Chinese Academy of Medical Sciences & Peking Union Medical College), Ran Zhang(Ministry of Education of the People's Republic of China)
Cited by 3
Related Papers
Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages
|Theranostics|2020|397
First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
|Journal of Hematology & Oncology|2022|149